G4S plc: Notification of Major Shareholding
11 January 2021
NOTIFICATION OF MAJOR SHAREHOLDING
The company was notified on 8 January 2021 by Morgan Stanley that, following an acquisition of voting rights attached to shares and voting rights relating to other financial instruments falling with DTR 5.3.1R(1) they hold 5.02% of the company's total voting rights.
For further enquiries, please contact:
||Director of Investor
|+44 (0) 207 9633189|
|Sophie McMillan||Head of media||+44 (0) 759 5523483|
|Press office||+44 (0) 207 9633333|
Notes to Editors:
G4S is the world’s leading global, integrated security company, specialising in the provision of security services and solutions to customers. Our mission is to create material, sustainable value for our customers and shareholders by being the supply partner of choice in all our markets.
G4S is quoted on the London Stock Exchange and has a secondary stock exchange listing in Copenhagen. After taking account of the businesses being sold in the year, G4S is active in around 85 countries and has around 533,000 employees. For more information on G4S, visit www.g4s.com .
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Thin Film Electronics ASA26.1.2021 18:03:44 CET | Press release
Thin Film Electronics ASA - Registration of Share Capital Increase
IPSOS26.1.2021 18:02:44 CET | Press release
Ipsos consolidates its Out-of-home measurement leadership with the acquisition of MGE Data
SOLUTIONS 3026.1.2021 18:01:44 CET | Press release
Solutions 30 : REMARKABLE REVENUE GROWTH IN 2020
EXEL INDUSTRIES26.1.2021 18:01:33 CET | Press release
Exel Industries :First quarter 2020-2021 revenue : A promising first quarter: 19% growth
NACON26.1.2021 17:46:33 CET | Press release
PRESS RELEASE: NACON AND DAEDALIC ENTERTAINMENT ARE FORMING A FELLOWSHIP TO PUBLISH AND DISTRIBUTE THE HIGHLY-ANTICIPATED THE LORD OF THE RINGS: GOLLUM
NTG Nordic Transport Group A/S26.1.2021 17:16:21 CET | Press release
Transactions in connection with share buyback program
Junshi Biosciences26.1.2021 16:37:10 CET | Press release
New data show treatment with etesevimab (JS016) and bamlanivimab together reduced risk of COVID-19 hospitalizations and death by 70 percent
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom